Manuel Crespo

1.4k total citations
40 papers, 927 citations indexed

About

Manuel Crespo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Manuel Crespo has authored 40 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 19 papers in Virology and 12 papers in Epidemiology. Recurrent topics in Manuel Crespo's work include HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (10 papers). Manuel Crespo is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (10 papers). Manuel Crespo collaborates with scholars based in Spain, Palestinian Territory and France. Manuel Crespo's co-authors include Esteban Ribera, Vicenç Falcó, Albert Pahissa, I Ocaña, Adrián Curran, Leonor Pou, Rosa María López, Daniel Podzamczer, Isabel Ruíz-Camps and Peré Domingo and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases and AIDS.

In The Last Decade

Manuel Crespo

39 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Crespo Spain 16 647 423 296 266 102 40 927
Herman G. Sprenger Netherlands 13 624 1.0× 391 0.9× 223 0.8× 396 1.5× 46 0.5× 41 994
Jaime E. Hernández United States 15 721 1.1× 531 1.3× 262 0.9× 472 1.8× 72 0.7× 38 1.1k
Jacques Gilquin France 13 447 0.7× 428 1.0× 315 1.1× 402 1.5× 48 0.5× 33 963
María Stella Mura Italy 16 394 0.6× 169 0.4× 349 1.2× 148 0.6× 55 0.5× 31 826
K. Squires United States 17 467 0.7× 259 0.6× 446 1.5× 131 0.5× 309 3.0× 22 948
Ryan Cooper Canada 12 562 0.9× 131 0.3× 277 0.9× 220 0.8× 29 0.3× 23 740
Edmund Wilkins United Kingdom 13 604 0.9× 443 1.0× 154 0.5× 305 1.1× 37 0.4× 24 777
Wouter F.W. Bierman Netherlands 14 361 0.6× 237 0.6× 96 0.3× 80 0.3× 159 1.6× 32 687
Michael J. Borucki United States 12 428 0.7× 166 0.4× 274 0.9× 182 0.7× 33 0.3× 22 632
M. A. Sambeat Spain 17 496 0.8× 422 1.0× 295 1.0× 354 1.3× 73 0.7× 24 879

Countries citing papers authored by Manuel Crespo

Since Specialization
Citations

This map shows the geographic impact of Manuel Crespo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Crespo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Crespo more than expected).

Fields of papers citing papers by Manuel Crespo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Crespo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Crespo. The network helps show where Manuel Crespo may publish in the future.

Co-authorship network of co-authors of Manuel Crespo

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Crespo. A scholar is included among the top collaborators of Manuel Crespo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Crespo. Manuel Crespo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crespo, Manuel, Jordi Navarro, Maria Martínez‐Rebollar, et al.. (2016). Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy. HIV Clinical Trials. 17(3). 89–95. 2 indexed citations
2.
Blanco, José Ramón, David Arroyo-Manzano, Manuel Crespo, et al.. (2015). The Efficacy and Safety of Maraviroc Addition to a Stable Antiretroviral Regimen in Subjects with Suppressed Plasma HIV-RNA Is Not Influenced by Age. AIDS Research and Human Retroviruses. 31(9). 893–897. 4 indexed citations
3.
4.
Domingo, Peré, Arkaitz Imaz, Estebán Martínez, et al.. (2014). Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group. Journal of Antimicrobial Chemotherapy. 69(5). 1390–1396. 15 indexed citations
5.
Riveira‐Muñoz, Eva, Eduardo Pauls, Marc Permanyer, et al.. (2014). Increased expression of SAMHD1 in a subset of HIV-1 elite controllers. Journal of Antimicrobial Chemotherapy. 69(11). 3057–3060. 23 indexed citations
6.
Molina, Israel, Roser Fisa, Cristina Riera, et al.. (2013). Ultrasensitive Real-Time PCR for the Clinical Management of Visceral Leishmaniasis in HIV-Infected Patients. American Journal of Tropical Medicine and Hygiene. 89(1). 105–110. 29 indexed citations
7.
Salvador, Fernando, Israel Molina, Elena Sulleiro, et al.. (2013). Tropical Diseases Screening in Immigrant Patients with Human Immunodeficiency Virus Infection in Spain. American Journal of Tropical Medicine and Hygiene. 88(6). 1196–1202. 43 indexed citations
8.
Burgos, Joaquín, Manuel Crespo, Vicenç Falcó, et al.. (2012). Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen. Journal of Antimicrobial Chemotherapy. 67(6). 1453–1458. 14 indexed citations
9.
Burgos, Joaquín, Manuel Crespo, Vicenç Falcó, et al.. (2012). Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 67(10). 2479–2486. 13 indexed citations
10.
Burgos, Joaquín, María Luz Pintos Peñaranda, Antoni Payeras, et al.. (2011). Invasive Pneumococcal Disease in HIV-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1). 31–38. 14 indexed citations
11.
Curran, Adrián, Estebán Martínez, María Saumoy, et al.. (2011). Body composition changes after switching from protease inhibitors to raltegravir. AIDS. 26(4). 475–481. 57 indexed citations
12.
Ribera, Esteban, Adrián Curran, Sílvia Sauleda, et al.. (2008). Improvements in Subcutaneous Fat, Lipid Profile, and Parameters of Mitochondrial Toxicity in Patients with Peripheral Lipoatrophy When Stavudine is Switched to Tenofovir (LIPOTEST Study). HIV Clinical Trials. 9(6). 407–417. 44 indexed citations
13.
Crespo, Manuel, et al.. (2008). Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART. Enfermedades Infecciosas y Microbiología Clínica. 26(1). 27–31. 4 indexed citations
14.
Curran, Adrián, Vicenç Falcó, Manuel Crespo, et al.. (2008). Bacterial pneumonia in HIV‐infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Medicine. 9(8). 609–615. 39 indexed citations
15.
Zamora, A.J., et al.. (2008). PROGNOSTIC VALUE OF PULSE PRESSURE REGISTERED BY 24 HOURS AMBULATORY BLOOD PRESSURE MONITORING IN ACUTE CORONARY SYNDROME. Atherosclerosis Supplements. 9(1). 149–149. 1 indexed citations
16.
Ribera, Esteban, Carlos Azuaje, Rosa María López, et al.. (2007). Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis. Journal of Antimicrobial Chemotherapy. 59(4). 690–697. 36 indexed citations
17.
Crespo, Manuel, Carlos Pigrau, Xavier Flores, et al.. (2004). Tuberculous Trochanteric Bursitis: Report of 5 Cases and Literature Review. Scandinavian Journal of Infectious Diseases. 36(8). 552–558. 8 indexed citations
18.
Crespo, Manuel, et al.. (2004). A Case of Multiorgan Failure Following Interruption of Antiretroviral Treatment. European Journal of Clinical Microbiology & Infectious Diseases. 23(1). 63–65. 4 indexed citations
19.
Falcó, Vicenç, Manuel Crespo, & Esteban Ribera. (2003). Lactic acidosis related to nucleoside therapy in HIV-infected patients. Expert Opinion on Pharmacotherapy. 4(8). 1321–1329. 19 indexed citations
20.
Santos, Fernando, et al.. (1999). Influence of three different types of hypercalciuria on bone. Pediatric Nephrology. 13(5). 396–400. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herman G. Sprenger Breakdown of academic impact, for papers by Jaime E. Hernández Breakdown of academic impact, for papers by Jacques Gilquin Breakdown of academic impact, for papers by María Stella Mura Breakdown of academic impact, for papers by K. Squires Breakdown of academic impact, for papers by Ryan Cooper Breakdown of academic impact, for papers by Edmund Wilkins Breakdown of academic impact, for papers by Wouter F.W. Bierman Breakdown of academic impact, for papers by Michael J. Borucki Breakdown of academic impact, for papers by M. A. Sambeat
Rankless by CCL
2026